Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation.

Li X, Liu X, Jiang Q, Wu Z, Han M, Chen Q, Idowu OO, Liu R, Liu W, Willis JR, Sun X

DOI: 10.1007/s40123-026-01378-1
Published: 2026 May
Container: Ophthalmology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40123-026-01378-1,
  title = {Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation.},
  author = {Li X and Liu X and Jiang Q and Wu Z and Han M and Chen Q and Idowu OO and Liu R and Liu W and Willis JR and Sun X},
  year = {2026},
  journal = {Ophthalmology and therapy},
  doi = {10.1007/s40123-026-01378-1},
  url = {https://doi.org/10.1007/s40123-026-01378-1}
}

RIS

TY  - JOUR
TI  - Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation.
AU  - Li X
AU  - Liu X
AU  - Jiang Q
AU  - Wu Z
AU  - Han M
AU  - Chen Q
AU  - Idowu OO
AU  - Liu R
AU  - Liu W
AU  - Willis JR
AU  - Sun X
PY  - 2026
JO  - Ophthalmology and therapy
DO  - 10.1007/s40123-026-01378-1
UR  - https://doi.org/10.1007/s40123-026-01378-1
ER  -

APA

X, L., X, L., Q, J., Z, W., M, H., Q, C., OO, I., R, L., W, L., JR, W., & X, S. (2026). Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation.. Ophthalmology and therapy. https://doi.org/10.1007/s40123-026-01378-1

Source records

pubmed · retrieved 2026-09-26T00:32:27.763Z